MD4502C1 - Drug in the form of gel for the treatment of periodontal diseases (embodiments) - Google Patents

Drug in the form of gel for the treatment of periodontal diseases (embodiments)

Info

Publication number
MD4502C1
MD4502C1 MDA20160139A MD20160139A MD4502C1 MD 4502 C1 MD4502 C1 MD 4502C1 MD A20160139 A MDA20160139 A MD A20160139A MD 20160139 A MD20160139 A MD 20160139A MD 4502 C1 MD4502 C1 MD 4502C1
Authority
MD
Moldova
Prior art keywords
extract
calculated
dry substance
periodontal diseases
gel
Prior art date
Application number
MDA20160139A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD4502B1 (en
Inventor
Раду БОЛУН
Валериу ФАЛА
Виктор ЛАКУСТА
Валериу РУДИК
Original Assignee
Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова filed Critical Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority to MDA20160139A priority Critical patent/MD4502C1/en
Publication of MD4502B1 publication Critical patent/MD4502B1/en
Publication of MD4502C1 publication Critical patent/MD4502C1/en

Links

Landscapes

  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to the field of medicine, namely to a sustained-action drug that can be used for treating periodontal diseases.The sustained-action drug in the form of gel for the treatment of periodontal diseases comprises a gelling agent 5.0…10.0 g, a plasticizer 0.5…2.0 g, sodium hypochlorite 0.5…1.0 g, collagen 5.0…10.0 g, hyaluronic acid sodium salt 0.5…2.0 g, dimethylsulfoxide 1.0…3.0 g, extract of mature nutshells (Juglans regia L.) calculated for dry substance 0.5…1.0 g, extract of Spirulina platensis cyanobacterium strain biomass calculated for dry substance 0.5…2.5 g and water 100 mL; it can also comprise extract of Calendula officinalis L. flowers calculated for dry substance 3.5…5.0 g and extract of Armoracia rusticana Lam. roots calculated for dry substance 0.5…1.0 g, or combinations thereof.
MDA20160139A 2016-12-15 2016-12-15 Drug in the form of gel for the treatment of periodontal diseases (embodiments) MD4502C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20160139A MD4502C1 (en) 2016-12-15 2016-12-15 Drug in the form of gel for the treatment of periodontal diseases (embodiments)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20160139A MD4502C1 (en) 2016-12-15 2016-12-15 Drug in the form of gel for the treatment of periodontal diseases (embodiments)

Publications (2)

Publication Number Publication Date
MD4502B1 MD4502B1 (en) 2017-08-31
MD4502C1 true MD4502C1 (en) 2018-03-31

Family

ID=59759575

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20160139A MD4502C1 (en) 2016-12-15 2016-12-15 Drug in the form of gel for the treatment of periodontal diseases (embodiments)

Country Status (1)

Country Link
MD (1) MD4502C1 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996026707A1 (en) * 1995-02-28 1996-09-06 U.S. Meds - Bulgaria Ltd. Composition for hygiene, prophylaxis and treatment of the oral cavity
RU2158125C1 (en) * 1999-11-17 2000-10-27 Санкт-Петербургская медицинская академия последипломного образования Composition for preventing and treating diseases of periodontium and oral cavity mucosa
RU2188627C1 (en) * 2001-04-26 2002-09-10 ООО НПО "Фитофарм" Method for preventing oral cavity diseases
RU2286764C1 (en) * 2005-06-16 2006-11-10 Георгий Георгиевич Ростиашвили Agent of prolonged action for treatment of mouth cavity inflammation diseases
JP2007037635A (en) * 2005-08-01 2007-02-15 Hitachi Medical Corp Gelled composition for periodontium regeneration
MD3905F1 (en) * 2008-05-07 2009-05-31 Valeriu Fala Remedy of durable action in the form of gel for treatment of parodentium affections (variants)
UA91666U (en) * 2014-02-24 2014-07-10 Роман Михайлович Федін Herbal gel composition for preventing and treating diseases of periodontium

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996026707A1 (en) * 1995-02-28 1996-09-06 U.S. Meds - Bulgaria Ltd. Composition for hygiene, prophylaxis and treatment of the oral cavity
RU2158125C1 (en) * 1999-11-17 2000-10-27 Санкт-Петербургская медицинская академия последипломного образования Composition for preventing and treating diseases of periodontium and oral cavity mucosa
RU2188627C1 (en) * 2001-04-26 2002-09-10 ООО НПО "Фитофарм" Method for preventing oral cavity diseases
RU2286764C1 (en) * 2005-06-16 2006-11-10 Георгий Георгиевич Ростиашвили Agent of prolonged action for treatment of mouth cavity inflammation diseases
JP2007037635A (en) * 2005-08-01 2007-02-15 Hitachi Medical Corp Gelled composition for periodontium regeneration
MD3905F1 (en) * 2008-05-07 2009-05-31 Valeriu Fala Remedy of durable action in the form of gel for treatment of parodentium affections (variants)
UA91666U (en) * 2014-02-24 2014-07-10 Роман Михайлович Федін Herbal gel composition for preventing and treating diseases of periodontium

Also Published As

Publication number Publication date
MD4502B1 (en) 2017-08-31

Similar Documents

Publication Publication Date Title
AU2018240515A1 (en) Nucleic acids encoding CRISPR-associated proteins and uses thereof
PH12020550032A1 (en) Gel comprising chlorhexidine
PH12017501583A1 (en) Novel proteins specific for cd137
PH12016500040A1 (en) Pcsk9 vaccine
MX352187B (en) Composition of dexibuprofen transdermal hydrogel.
MD3905G2 (en) Remedy of durable action in the form of gel for treatment of parodentium affections (variants)
PH12015502535B1 (en) Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes
TN2015000520A1 (en) Pharmaceutical compositions comprising collagen and sodium hyaluronate
EA201690005A1 (en) COMPOSITION WITH MODIFIED EXTRUSION KINETICS
JP2016535794A5 (en) Rapidly disintegrating solid dosage form
MD3904G2 (en) Composition for biosoluble medicated film for treatment of parodentium affections and of lesions of tunica mucosa of mouth (variants)
MD4502C1 (en) Drug in the form of gel for the treatment of periodontal diseases (embodiments)
MD4503C1 (en) Composition for medicated film for the treatment of periodontal diseases and lesions of tunica mucosa of mouth (embodiments)
CY1117777T1 (en) TREATMENT MEDICINAL COMPOSITIONS FOR LOCAL APPLICATIONS INCLUDING SUCRALFATI GELS
BR112021006621A2 (en) composition of cell regeneration and anti-aging, process of obtaining extracts of alerce cells (fitzroya cupressoides) and method of treatment of human beings
MX2015017857A (en) Biodegradable covalent matrices for theoral delivery of insulin directed to the colon, activated by microbiota, and production method thereof
PH12015500070A1 (en) Pediatric oral liquid compositions containing nepadutant
LV13959A (en) Adenylate deaminase containing hidrogel and use thereof for the treatment of dermal wounds (ulcers)
MD2975F1 (en) Remedy in the form of gel for rosacea treatment
CZ20131035A3 (en) Hydrogel for external treatment of mucous membranes
MX360021B (en) Psacalium decompositum methanol extract and its use as dental anti-calculus agent.
RU2008116529A (en) MEDICINAL PREVENTIVE MEANS
Wang Bin et al. Observation of efficacy of Fluorine methods material and Modified chitin xanthan gum in treatment of oral Helicobacter pylori infection.
MD2976G2 (en) Remedy in the form of gel for acnea treatment
MD746Y (en) Method for disinfection of the root canal

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees